DNAiTECH is contributing to a new project, “Development of a Molecular Rapid Detection Test for Measles Virus Diagnosis” supported by Grand Challenges Canada funding to Fondation Institut Pasteur de Dakar.
Measles is a serious and highly contagious disease. It can cause serious problems, including brain swelling, chest infections, or death. Since covid, there has been a resurgence of measles cases worldwide, caused by a reduction in vaccination during the pandemic and a rise in vaccine hesitancy.
At DNAiTECH we have developed PLACID, “paper-based LAMP CRISPR integrated diagnostics. This is a diagnostic chip technology, enabling the definitive molecular detection of pathogens. We anticipate trials with PLACID diagnostic chips for measles and rubella to be tested with scientists from the Fondation Institut Pasteur de Dakar in Senegal in early 2025.
Comments